Hippo–YAP Pathway Dysregulation and Prognostic Implications in HPV-Negative Oropharyngeal Carcinomas
Cancers · 20.07.2026 · 18 (14) · 2337
DOI: 10.3390/cancers18142337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 20.07.2026. Verfasst von Ernesto Martín-Guillermo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Hospital Universitario Central de Asturias, Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Gobierno del Principado de Asturias, European Union.
Abstract (Originalsprache)
Background
Human papillomavirus (HPV)-unrelated oropharyngeal squamous cell carcinoma (OPSCC) is a clinically aggressive disease characterized by poor outcomes and limited prognostic biomarkers. The Hippo–YAP pathway has emerged as a key regulator of tumorigenesis in epithelial cancers, although its role in OPSCC remains incompletely defined.
Methods
We conducted a retrospective study including 215 patients with HPV-negative OPSCC treated surgically with curative intent. Tissue microarrays were constructed, and immunohistochemical analysis of YAP1 and TAZ expression was performed. Associations with clinicopathological variables, disease-free survival (DFS) and disease-specific survival (DSS) were assessed using univariable and multivariable analyses.
Results
Nuclear and cytoplasmic YAP1 expression were detected in 53% and 85.6% of tumors, respectively. Both nuclear and cytoplasmic YAP1 expression were significantly associated with reduced DFS (p = 0.019 and p = 0.004, respectively) and DSS (p = 0.01 and p = 0.006, respectively). Multivariable analysis identified nodal involvement (HR = 1.64, p = 0.023) and nuclear YAP1 expression (HR = 1.65, p = 0.004) as independent predictors of DFS, and advanced tumor stage (HR = 1.57, p = 0.038), nodal involvement (HR = 2.34, p < 0.001), and nuclear YAP1 expression (HR = 1.78, p = 0.002) as independent predictors of DSS. In contrast, nuclear TAZ expression was observed at a lower frequency (14.5%) and showed no significant association with clinical parameters or survival outcomes.
Conclusions
YAP1 expression, particularly its nuclear activated form, emerges as an independent poor prognostic factor in HPV-negative OPSCC, whereas nuclear TAZ expression was rather infrequent and showed no clinical relevance. These findings highlight the importance of Hippo pathway dysregulation in this tumor subtype and suggest the potential of YAP1 as both a prognostic biomarker and a therapeutic target.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Hospital Universitario Central de Asturias, Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.
- Head and Neck Cancer Research Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.
- Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, c/Julian Clavería s/n, 33006 Oviedo, Spain.
- Spanish Biomedical Research Network in Cancer (CIBERONC), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.
- Maxillofacial Oncology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.
- Biobanco del Principado de Asturias (BioPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.
ORCID-Profile: Ernesto Martín-Guillermo, Israel Rivera-García, Daniela Corte-Torres, Corina Lorz, Juana M García-Pedrero, Juan P Rodrigo
Förderung
- Instituto de Salud Carlos III
- Gobierno del Principado de Asturias
- European Union
- Instituto de Investigación Sanitaria del Principado de Asturias
- Fundación Bancaria Caja de Ahorros de Asturias-IUOPA, Universidad de Oviedo
- Government of Principado de Asturias
Zitieren
APA
Martín-Guillermo, E., Rivera-García, I., Álvarez-Alonso, A., Guizán-Alonso, C., García-Torre, A., Corte-Torres, D., Lorz, C., García-Pedrero, J. M., & Rodrigo, J. P. (2026). Hippo–YAP Pathway Dysregulation and Prognostic Implications in HPV-Negative Oropharyngeal Carcinomas. Cancers, 18(14), 2337. https://doi.org/10.3390/cancers18142337
Vancouver
Martín-Guillermo E, Rivera-García I, Álvarez-Alonso A, Guizán-Alonso C, García-Torre A, Corte-Torres D, et al. Hippo–YAP Pathway Dysregulation and Prognostic Implications in HPV-Negative Oropharyngeal Carcinomas. Cancers. 2026;18(14):2337. doi:10.3390/cancers18142337
BibTeX
@article{MartnGuillermo2026,
author = {Martín-Guillermo, Ernesto and Rivera-García, Israel and Álvarez-Alonso, Ana and Guizán-Alonso, Carlota and García-Torre, Alejandra and Corte-Torres, Daniela and Lorz, Corina and García-Pedrero, Juana M and Rodrigo, Juan P},
title = {Hippo–YAP Pathway Dysregulation and Prognostic Implications in HPV-Negative Oropharyngeal Carcinomas},
journal = {Cancers},
year = {2026},
volume = {18},
number = {14},
pages = {2337},
doi = {10.3390/cancers18142337}
}
EUVIMED